Indoco Remedies

Top stocks to buy in 2021: HCL Tech, Divi’s Labs among 7 stocks that may rally up to 28% in new year

Indian share markets staged a smart recovery in the calendar year 2020, rallying around 84 per cent from the March lows.

Indigo paints, ipo, initial public offer

Indoco Remedies Q4 net profit rises 6.7 per cent to Rs 20 crores aided by exports

Recommends 10 per cent final dividend in addition to 70 per cent interim dividend announced earlier

Indoco Remedies receives US FDA nod for Goa manufacturing facility

The approval confirms the closure of inspection conducted in July 2015

Maharashtra, the pharma capital

Suresh G Kare, Chairman, Indoco Remedies, elaborates why Maharashtra has been a preferred destination for the pharma sector

Indoco Remedies shares surge 11% on USFDA nod for Goa plant

In the past one year, Indoco Remedies slipped 20.83 per cent to Rs 267.35 till March 21, whereas the BSE Sensex plunged 10.31 per cent during the same period.

Sensex, Nifty, bse, nse

Indoco Remedies receives USFDA nod for solid dosages plant I in Goa

The plant has a capacity to manufacture 2.2 billion tablets, 32 million bottles of liquid orals, 16 million tubes of creams and ointments and 60 million capsules of hard gelatin

KM Kundnani College of Pharmacy celebrates 45th Annual Day

A slew of activities were held to commemmorate the event

Indoco Remedies plans Rs 125 crore investment

Posts net profit of Rs 20.3 crore compared to Rs 18.7 crore Indoco Remedies has planned an investment of Rs 125 crore for expansion of its sterile ophthalmic facility at Goa and for setting up a green field API facility at Pa

Indoco Remedies posts net revenues at Rs 212 crores

Board recommends dividend of Rs 1.60 per equity share During the quarter under review, the net revenues of Indoco Remedies grew by 13.8 per cent to Rs 211.6 crores as against Rs 185.9 crores for the same period last year. The

Aditi Kare Panandikar receives the Ohio State University Award

She received the award for her outstanding contribution to the pharma industry

Indoco acquires Piramal’s clinical research division

This facility is spread across an area of 30,000 sq ft and is equipped with a 98-bed facility

Indoco buys Piramal’s research wing

Mumbai-based Indoco Remedies has announced the acquisition...

Indoco Remedies Q3 PAT grows by 53 per cent

Net revenues during the quarter under review grew by 13 per cent to Rs 212.9 crores as against Rs 188.4 crores for the same period last year

Advertisement
Income Tax Calculator, Budget 2019, How to Calculate Income Tax

 

Stock Market

Most Read

Advertisement

Top News

Advertisement

Related Articles